| Code | CSB-RA011661MB12HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to reference antibody TQH2722, targeting the interleukin-4 receptor (IL4R). IL4R is a type I transmembrane protein that serves as a critical component of receptor complexes for both IL-4 and IL-13, two key cytokines involved in type 2 immune responses. Upon ligand binding, IL4R initiates signaling cascades that regulate B cell class switching to IgE, promote Th2 cell differentiation, and drive alternative macrophage activation. Dysregulated IL4R signaling is implicated in allergic diseases, asthma, atopic dermatitis, and certain fibrotic conditions, making it an important therapeutic target in inflammatory and immune-mediated disorders.
As a biosimilar to TQH2722, this antibody provides researchers with a reliable tool for investigating IL4R-mediated signaling pathways and their roles in immune regulation and disease pathogenesis. It supports studies exploring type 2 inflammation mechanisms, cytokine receptor biology, and potential therapeutic interventions for allergic and inflammatory conditions. This product is suitable for various immunological research applications requiring specific IL4R detection or functional modulation.
There are currently no reviews for this product.